Selumetinib shows promise in ovarian cancerOral MEK inhibitor produces ‘striking’ results in early clinical trial Hypoxia predicts prostate cancer recurrenceLow tumour oxygenation linked with biochemical relapse within 48 months of treatment Metformin slows prostate cancer growth Small Canadian study measures markers of cell proliferation Trials fine-tune treatment of low-risk thyroid cancer Less radioiodine as effective as higher dose, studies show Beware circulating cells New study backs flexible sigmoidoscopy as screening tool Major U.S. trial shows reduction in colorectal cancer mortality Scan kids with caution Male pattern baldness linked to prostate cancer But finger-length ratio not a risk factor, Canadian study shows Statins may slow prostate growth Finding emerges from secondary analysis of dutasteride trial Target colorectal screening based on life expectancy Analysis shows lag-time for benefit exceeds 10 years First Previous 51 52 53 54 55 Next Last
